Oncology Pharma (ONPH) News Today → Estee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI company (From Financial Markets Daily) (Ad) Free ONPH Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | bizjournals.comWeston company receives FDA designation for pancreatic cancer drugMay 22, 2024 | benzinga.comGlobal Pharma Giants Are Betting Big On Oncology But Without Daring To Tackle Cancer PreventionMay 18, 2024 | reuters.comEU regulator scraps approval for pregnancy drug over cancer riskMay 16, 2024 | msn.comAmerican Oncology Network GAAP EPS of -$1.22, revenue of $364.34MMay 10, 2024 | msn.comEnding Oncology's Toxic Relationship With High Chemotherapy DosesMay 7, 2024 | msn.comThe FDA targets pharma’s grip on costly, toxic cancer drug dosagesMay 3, 2024 | news.yahoo.comCoach's death spotlights pharma's profit wins in chemo drug shortageMay 2, 2024 | marketwatch.comNovartis to Buy Mariana Oncology for Up to $1.75 Bln in Boost to Radioligand Therapy BusinessApril 30, 2024 | msn.comONO to acquire Deciphera Pharmaceuticals in $2.4B dealApril 30, 2024 | yahoo.comJapan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansionApril 29, 2024 | benzinga.comWhy Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?April 29, 2024 | msn.comDeciphera stock soars after Ono Pharmaceutical’s $2.4B buyout dealApril 23, 2024 | bizjournals.comPeninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kidsApril 17, 2024 | markets.businessinsider.comNika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary SupplementApril 12, 2024 | bloomberg.comNuclear Medicine Is Big Pharma’s New Target in Cancer RaceApril 10, 2024 | businesswire.comOnchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective TreatmentApril 9, 2024 | msn.comBoehringer Ingelheim Upbeat On China, Forms Cancer Drug PartnershipApril 4, 2024 | msn.comKintara and TuHURA enter merger deal to advance oncology pipelineApril 4, 2024 | msn.comCancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led roundApril 4, 2024 | msn.comA new hope in immunotherapy against cancerMarch 26, 2024 | msn.comRegeneron's blood cancer therapy faces setback as FDA raises trial concernsMarch 25, 2024 | msn.comUS FDA declines to approve Regeneron's blood cancer therapyMarch 21, 2024 | bizjournals.comClinical trial results show new Penn technology could be the key to fighting brain cancerMarch 12, 2024 | msn.comAbilityPharma receives funds to advance pancreatic cancer trialMarch 4, 2024 | msn.comIovance stock rises after FDA lifts clinical hold on lung cancer trialFebruary 27, 2024 | benzinga.comOncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and DatesFebruary 27, 2024 | benzinga.comOncology Pharma Stock (OTC:ONPH), Analyst Ratings, Price Targets, PredictionsFebruary 20, 2024 | msn.comThe doctor behind the next big thing in cancer treatmentFebruary 20, 2024 | msn.comThe woman behind the next big thing in cancer treatmentFebruary 19, 2024 | msn.comPositive signs for new cancer treatment after trial on Oxford patientsFebruary 17, 2024 | msn.comUPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapyFebruary 16, 2024 | reuters.comUS FDA grants accelerated approval for Iovance's skin cancer cell therapyFebruary 15, 2024 | msn.comCancer breakthrough as doctors celebrate new ‘wonder drug’February 15, 2024 | msn.comOno and Numab to develop antibody for cancer treatmentFebruary 9, 2024 | msn.comBoehringer and CBmed partner to develop cancer therapiesFebruary 4, 2024 | tmcnet.comAccord Healthcare partners with ITN Business for World Cancer Day to explore how innovative approaches are helping shape the future of cancer careFebruary 2, 2024 | msn.comNeoPhore adds $12.2m in Series B extension for immuno-oncology pipelineJanuary 30, 2024 | msn.comKiromic BioPharma reports data from lung cancer therapy trialJanuary 29, 2024 | marketwatch.comNanobiotix Gets $20M Milestone Payment for Head and Neck Cancer Study From JanssenJanuary 29, 2024 | markets.businessinsider.comHOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership ProgramsJanuary 27, 2024 | seekingalpha.comU.S. IPO Weekly Recap: Biotech CG Oncology Pops 96% In A 7 IPO WeekJanuary 26, 2024 | marketwatch.comCorbus Pharmaceuticals' Shares Triple Following Results From Phase 1 Cancer StudyJanuary 26, 2024 | msn.comCorbus Pharma surges after early Phase 1 data for tumor candidateJanuary 25, 2024 | msn.comCG Oncology IPO rockets 96% in sign of pent-up deal demandJanuary 25, 2024 | money.usnews.comCG Oncology Valued at $1.75 Billion in Strong Market DebutJanuary 25, 2024 | reuters.comCG Oncology valued at $1.75 bln in strong market debutJanuary 24, 2024 | marketwatch.comKura Oncology Shares Rally After Oversubscription to OfferingJanuary 23, 2024 | msn.comCG Oncology upsizes proposed IPO to $289M from $201MJanuary 18, 2024 | msn.comCG Oncology upsizes proposed IPO to $201M from $100MJanuary 12, 2024 | msn.comQ&A: Exploring the challenges behind oncology trials Get Oncology Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPH and its competitors with MarketBeat's FREE daily newsletter. Email Address "The Biggest Drug Ever" Is Coming (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> ONPH Media Mentions By Week ONPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONPH News Sentiment▼0.000.88▲Average Medical News Sentiment ONPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONPH Articles This Week▼02▲ONPH Articles Average Week Get Oncology Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Artificial Life News Today Code Rebel News Today Full Truck Alliance News Today Interplay Entertainment News Today Karooooo News Today Net Medical Xpress Solutions News Today Quantum Solar Power News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ONPH) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored